deListed Australia
Any AUS or NZ company

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:


ASX Announcements (courtesy of ASX)


ASX, Legal & CGT Status


(updated at weekends)
Former (or subsequent) names
Shareholder links


Computershare Sydney
Level 3, 60 Carrington Street, Sydney NSW 2000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 2 8235 8150
RegistryWebsite RegistryEmail

Company details
Address: C/- Altus Financial, Level 12, 10 Spring Street, SYDNEY, NSW, AUSTRALIA, 2000
Tel:  61 2 8908 3444 Fax: 61 2 8908 3455

Date first listed: 20/08/1996

Sector: Pharmaceuticals & Biotechnology
Industry Group: XHJ
Activities: Chemically re-engineer drugs to improve performance (potentially reducing dosage and side effects) and allowing use of more efficient, patient-friendly, drug delivery options ie. oral, inhalational, injectable, transdermal and implants

company deregistered today


delisted from the close of trading on Thursday, 31 December 2015, pursuant to Listing rule 17.12 and Guidance Note 33


we understand that it is ASX policy to automatically remove from the official list any entity whose securities have been suspended from trading for a continuous period of 3 years


At the Extraordinary General Meeting of the company held on 29th August 2013, the shareholders approved the consolidation of the company's shares on the basis of one share for every 6.68358 shares held, subject to the completion of the company's acquisition of Mimetica Pty Limited. As the acquisition of Mimetica is not proceeding, the company no longer has the approval of shareholders to undertake a share consolidation and therefore will not be proceeding with this course of action


the public offer of securities to be made pursuant to a prospectus dated 19 August 2013 closed undersubscribed at 5pm AEST on 18 October 2013. Telesso has not raised the minimum subscription under the prospectus. As a result, the proposed acquisition by Telesso of all of the issued shares in the capital of Mimetica Pty Ltd (Mimetica) will not complete and the share purchase agreement between Telesso and the securityholders of Mimetica has been terminated. Further, no securities will be issued under the prospectus, and all application monies received under the prospectus will be repaid


a supplementary prospectus is dated 27 September 2013 and is lodged with ASIC


releases Annual Report to shareholders


it is our understanding a share consolidation is about to take place whereby 6.68358 existing shares are consolidated into one share


issues a prospectus for an offer to raise a minimum of $6,500,000 through the offer of a minimum of 26,000,000 Shares at $0.25 each. With an entitlement for each existing Telesso Technologies Limited shareholder who applies for at least 8,000 Shares under this Prospectus to receive 2,000 unlisted free-attaching Loyalty Options. The Offer is conditional upon the shareholders of Telesso Technologies Limited approving a change in the nature and scale of Telesso" activities and the issue of the Shares referred to in this Prospectus at a general meeting of Telesso Technologies Limited to be held on 29 August 2013


as outlined in the letter to shareholders on 31 May 2013, and as part of the company acquisition of Mimetica Pty Limited, the company yesterday lodged a prospectus with ASIC to raise $6,500,000


On 15 April 2013, Telesso announced plans to acquire all of the issued capital of Mimetica Pty Ltd ("Mimetica"), a private Australian biotechnology company focused on the development of new prescription treatments for Acne vulgaris (acne). A copy of that announcement is attached and I draw your attention to the important details of the proposed acquisition outlined within that document. At the time of writing, Telesso is finalising advice from the Australian Securities Exchange (ASX) on certain aspects of the proposed transaction. This advice will allow Telesso to establish a definitive schedule of events, including convening a meeting of shareholders. Should shareholders approve the acquisition, a capital raising to fund the merged entit" clinical development program will follow. Further announcements will be made by Telesso in the near future


releases Half Yearly Report and Accounts


Telesso Technologies Limited requests, pursuant to ASX Listing Rule 17.2, that the quotation of its securities (being fully paid ordinary shares) be suspended from December 17, 2012. It is expected that the suspension will last approximately six months.


The securities of Telesso Technologies Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, in accordance with listing rules 12.1 and 12.3. Security Code: TEO


name changed from Eiffel Technologies Limited

View ASX Announcements (courtesy of ASX)


Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.
Loading comments....  Most recent comments

can I sell those shares to you, please email:

12/07/2016 17:49:04

?Dear Sir / Madam,


May we know as to when will your Company\'s shares (TEO) will resume trading; we hold 17,500 shares of your Company.


Your share registry, M/s.Computershare Australia informed us to contact you directly and hence this letter addressed to you.




Yours sincerely,


Suresh Bangaruswamy



Thanuja Suresh.



03 DEC 2015

03/12/2015 17:10:13

Could anyone please advise how to dispose of Telesso (TEO) shares, which have been suspended from trading for almost 12 months?


20/02/2014 11:34:37
Company Updates
Post your comments here
Please read our Terms before posting comments.
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)


    Click here for the last 20 transactions all companies

    Directors & Executives (current)
    Michael HoyNon Exec Chairman20/12/2005
    John EbellDirector22/06/2015
    Harry DoumbosDirector22/06/2015
    Manoj SingholageDirector22/06/2015
    Justyn StedwellCompany Secretary

    Date of first appointment, title may have changed.

    SPECIAL NOTE: During May 2024 we are working to remove duplications in the Company Secretary role.

    Directors & Executives (former)
    Michael YoungDirector18/11/201322/06/2015
    Robert PartonDirector18/11/201322/06/2015
    Samuel ArmytageDirector, CFO18/11/201322/06/2015
    Ian AtkinCFO07/11/200518/11/2013
    Lawrence GozlanNon Exec Director01/04/200718/11/2013
    Ross MacDonaldNon Exec Director20/02/200318/11/2013
    Cherrell HirstDirector09/10/201201/11/2013
    Doug McTaggartNon Exec Director01/11/200709/10/2012

    Date of first appointment, title may have changed.